Soligenix gets patent for ricin vax; Kamada negotiating agreement for rabies jab;

Vaccine Research

Soligenix, a late-stage biopharmaceutical company, announced today that the USPTO has granted patent #7,829,668, titled "Compositions and methods for modifying toxic effects of proteinaceous compounds." This patent includes composition claims for the modified ricin toxin A chain which is the immunogen contained in RiVax. Soligenix release

Kamada is in advanced negotiations with an international pharmaceutical company, whose name it did not disclose, on a strategic cooperation agreement to complete clinical development and distribution of Kamada's KamRAB rabies vaccine. News

Vaccine Market

The legendary Australian immunologist who drove the eradication of smallpox and control of the 1950s rabbit plague died yesterday, aged 95. Frank "Bunny" Fenner was a brilliant scientist and philanthropist who made generous donations to the John Curtin School of Medical Research--which he headed until 1973--and the Australian Academy of Science, of which he was a founding fellow. He was also an advocate for public health. Article

Special Report:Top 10 Pharma CEO salaries of 2009. Report

Bill Gate's eureka moment came in June 2009 in an underground conference room at the World Health Organization's headquarters in Geneva. After a decade of giving away millions to eradicate polio, the billionaire philanthropist was being briefed on hours-old data showing how two doses of a new polio vaccine protected 37 percent more children than conventional ones. Story

Evey Jane, 3, has never experienced the dog flu, and her owner wants to make sure it stays that way. Evey got her annual prick in the shoulder, just like her human owner would to combat the seasonal flu. The dog flu was first discovered in 2004 when an unknown respiratory illness began showing up in racing greyhounds in Florida. Story

A set of new Canadian guidelines for childhood immunizations intended to reduce pain have been put forward by a panel of experts from across Canada. The guidelines were published in the Canadian Medical Association Journal on Monday. Report

Special Report: The 2010 Biotech Graveyard. Report

Suggested Articles

Merck & Co. inked a series of deals to advance three COVID-19 projects, trailing some of its large pharma peers into the industrywide research effort.

With a new £131 million contribution from the U.K. government, VMIC aims to both speed up and expand on its prior ambitions.

AstraZeneca scored a $1 billion contribution from the United States for development, production and delivery of its potential COVID-19 vaccine.